26.78USD+0.26%Mkt Cap: 1.23B $P/E: —1d ago
Azenta, Inc. provides biological and chemical compound sample exploration and management solutions for the life sciences industry in the United States, China, the United Kingdom, rest of Europe, the Asia Pacific, and int…
Industry Peers
Medical Instruments & Supplies$142.49BUSDP/E 48.8
$84.67BUSDP/E 34.0
$73.25BUSDP/E 36.1
$44.07BUSDP/E 27.9
$31.69BUSDP/E 42.2
$29.41BUSDP/E 19.6
$25.61BUSDP/E 48.5
$19.82BUSDP/E 67.9
$18.23BUSDP/E 44.9
$18.54BUSDP/E 105.1
$14.74BUSDP/E 83.6
$13.59BUSDP/E 44.2
$14.26BUSDP/E 61.9
$14.15BUSDP/E 10.0
$12.78BUSDP/E 30.0
$12.06BUSD
$8.60BUSDP/E 23.1
$8.38BUSDP/E 165.1
$7.69BUSD
$5.63BUSDP/E 23.0
$5.99BUSDP/E 1931.7
$4.53BUSDP/E 30.5
$4.51BUSDP/E 32.6
$4.46BUSD
$4.39BUSDP/E 65.8
$4.03BUSDP/E 40.3
$4.05BUSDP/E 87.2
$3.67BUSDP/E 16.5
$3.32BUSDP/E 21.4
$3.39BUSDP/E 2759.0
$2.85BUSDP/E 21.9
$2.63BUSD
$2.77BUSD
$2.35BUSDP/E 37.9
$1.95BUSDP/E 36.0
$1.89BUSD
$1.80BUSD
$1.48BUSD
$1.44BUSD
$1.29BUSDP/E 74.9
$1.41BUSD
$1.09BUSD
$752.64MUSDP/E 16.0
$811.83MUSD
$756.96MUSDP/E 14.8
$671.62MUSDP/E 39.2
$660.94MUSDP/E 55.9
$584.44MUSD
$360.76MUSDP/E 21.2
$354.68MUSDP/E 17.1
$272.64MUSD
$245.88MUSDP/E 13.6
$232.03MUSDP/E 422.0
$211.00MUSDP/E 35.6
$228.42MUSDP/E 21.2
$198.25MUSDP/E 23.8
$198.75MUSDP/E 1.8
$194.76MUSD
$188.63MUSDP/E 16.3
$160.12MUSD
$164.06MUSD
$123.68MUSDP/E 39.3
$115.11MUSD
$120.22MUSD
$107.50MUSD
$61.36MUSDP/E 6.4
$59.94MUSD
$48.70MUSD
$40.82MUSDP/E 53.7
$41.23MUSDP/E 41.0
$37.15MUSD
$32.43MUSD
$26.84MUSD
$25.35MUSDP/E 176.7
$20.69MUSD
$18.82MUSD
$14.75MUSD
$14.58MUSD
$13.43MUSD
$9.21MUSD
$7.52MUSDP/E 12.9
$7.46MUSD
$5.06MUSD
$4.00MUSD
$465.9KUSD
$138.6KUSD
Indicators:|
Key Statistics
Company
Market Cap1.23B $
Enterprise Value909.56M $
Revenue (TTM)596.48M $
Gross Profit270.28M $
Net Income (TTM)-55.76M $
Revenue/Share12.99 USD
Last Price26.78 USD
Fiscal Year EndSep 2025
MR QuarterMar 2026
Employees2.9K
CountryUS
SectorHealthcare
IndustryMedical Instruments & Supplies
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)43.62
PEG0.53
EV/EBITDA24.77
EV/Revenue1.52
P/S2.07
P/B0.79
EPS (TTM)-2.41
EPS (Forward)0.61
52W Range
15.9342% of range41.73
52W High41.73 USD
52W Low15.93 USD
Profitability
Gross Margin45.52%
Oper. Margin-10.56%
EBITDA Margin6.16%
Profit Margin-9.39%
ROE-3.23%
ROA-2.71%
Growth
Revenue Growth1.00%
Earnings Growth—
Cash Flow & Leverage
Operating CF72.18M $
CapEx (TTM)33.86M $
FCF Margin16.99%
FCF Yield8.21%
Net Debt-324.81M $
Net Debt/EBITDA-8.85
Balance Sheet
Debt/Equity0.03
Current Ratio2.83
Quick Ratio2.12
Book Value/Sh33.73 USD
Cash/Share8.255 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield0.83%
Payout Ratio0.00%
Ex-Div DateDec 2, 2021
Pay DateDec 23, 2021
Analyst Consensus
Rating2.2 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)26.20 USD
Upside (mean)-2.2%
Target Range20.00 USD – 33.00 USD
$20.00-2.2% to mean$33.00
# Analysts5
Ownership
Shares Out.46.09M
Float40.60M
Insiders1.00%
Institutions116.86%
Short Interest
Short Ratio7.1d
Short % Float21.25%
Short % Out.13.50%
Shares Short6.22M
Short (prev mo.)5.87M
Technical
SMA 5022.34 (+19.9%)
SMA 20028.23 (-5.1%)
Beta1.37
S&P 52W Chg20.25%
Avg Vol (30d)721.45K
Avg Vol (10d)617.83K
Technical Indicators
RSI (14)67.5
MACD1.0133
MACD Signal0.9504
MACD Hist.+0.0629
BB Upper27.75 USD
BB Middle24.87 USD
BB Lower21.99 USD
BB Width23.14%
ATR (14)1.140 USD
Vol Ratio (20d)0.99x